These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25543975)

  • 1. Why should cardiologists consider genetic testing for hypertrophic cardiomyopathy?
    Judge DP
    JACC Heart Fail; 2015 Feb; 3(2):189-91. PubMed ID: 25543975
    [No Abstract]   [Full Text] [Related]  

  • 2. Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.
    Ho CY; Lakdawala NK; Cirino AL; Lipshultz SE; Sparks E; Abbasi SA; Kwong RY; Antman EM; Semsarian C; González A; López B; Diez J; Orav EJ; Colan SD; Seidman CE
    JACC Heart Fail; 2015 Feb; 3(2):180-8. PubMed ID: 25543971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of cardiomyopathy using Ca blockers].
    Matsumori A; Tominaga M; Kawai C
    Nihon Rinsho; 1989 Aug; 47(8):1825-30. PubMed ID: 2585747
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of calcium channel blockers.
    Mayer WP
    Alaska Med; 1984; 26(1):10-2. PubMed ID: 6539573
    [No Abstract]   [Full Text] [Related]  

  • 5. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual papillary muscle hypertrophy in a septuagenarian.
    Patil NP; Katti K
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):704-5. PubMed ID: 21458009
    [No Abstract]   [Full Text] [Related]  

  • 7. New perspectives in the pharmacological treatment of hypertrophic cardiomyopathy.
    Maltês S; Lopes LR
    Rev Port Cardiol (Engl Ed); 2020 Feb; 39(2):99-109. PubMed ID: 32245685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers. New treatment for cardiovascular disease.
    Rossi LP; Antman EM
    Am J Nurs; 1983 Mar; 83(3):382-7. PubMed ID: 6550460
    [No Abstract]   [Full Text] [Related]  

  • 9. [Calcium antagonists. Concept and therapeutic applications].
    Eichelbaum M
    Med Welt; 1982 Aug; 33(31-32):1079-82. PubMed ID: 6890137
    [No Abstract]   [Full Text] [Related]  

  • 10. Time to Think Differently About Sarcomere-Negative Hypertrophic Cardiomyopathy.
    Watkins H
    Circulation; 2021 Jun; 143(25):2415-2417. PubMed ID: 34152793
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy--beyond the sarcomere.
    St John Sutton M; Epstein JA
    N Engl J Med; 1998 Apr; 338(18):1303-4. PubMed ID: 9562586
    [No Abstract]   [Full Text] [Related]  

  • 12. [Calcium antagonists in cardiology].
    Tullio D; Valerio A; D'Agostino F
    Clin Ter; 1983 Jan; 104(1):27-51. PubMed ID: 6337771
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetics of hypertrophic cardiomyopathy in Norway.
    Berge KE; Leren TP
    Clin Genet; 2014 Oct; 86(4):355-60. PubMed ID: 24111713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Is the True Prevalence of Hypertrophic Cardiomyopathy?
    Baudhuin LM; Kotzer KE; Kluge ML; Maleszewski JJ
    J Am Coll Cardiol; 2015 Oct; 66(16):1845-1846. PubMed ID: 26483113
    [No Abstract]   [Full Text] [Related]  

  • 15. Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy.
    Westermann D; Knollmann BC; Steendijk P; Rutschow S; Riad A; Pauschinger M; Potter JD; Schultheiss HP; Tschöpe C
    Eur J Heart Fail; 2006 Mar; 8(2):115-21. PubMed ID: 16214409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sarcomere gene mutations--a cause of hypertrophic cardiomyopathy].
    Kuusisto J; Jääskeläinen P; Laakso M
    Duodecim; 1999; 115(9):997-8. PubMed ID: 11877825
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy: can the horse be put back in the barn?
    Wheeler MT; Ashley EA
    J Am Coll Cardiol; 2015 Feb; 65(6):570-2. PubMed ID: 25677316
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium channel blocking agents. Council on scientific affairs.
    JAMA; 1983 Nov; 250(18):2522-4. PubMed ID: 6685194
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy.
    Ommen SR
    Curr Probl Cardiol; 2011 Nov; 36(11):409-53. PubMed ID: 21962729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting risk stratification in hypertrophic cardiomyopathy: do we need to start from scratch?
    Lee MS; Macrae CA
    Heart Rhythm; 2012 Jan; 9(1):64-5. PubMed ID: 22019864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.